Johnson & Johnson (JNJ)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$244.92

Buy

$245.07

arrow-up$0.555 (+0.23%)

Prices updated at 01 Apr 2026, 16:45 EDT

Prices minimum 15 mins delay

Prices in USD

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

S&P 500

1.08%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	88,821m	94,193m
	61,350m	63,937m
	21,249m	25,596m
	23.92	27.17
	14,066m	26,804m
	24,781m	41,055m
Sales, General and administrative	22,869m	23,676m
Interest expenses	755m	971m
Provision for income taxes	2,621m	5,777m
Operating expenses	40,101m	38,341m
Income before taxes	16,687m	32,581m
Net income available to common shareholders	14,066m	26,804m
	5.84	11.13
Net interest income	577m	85m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	5.79	11.03
Free cash flow per share	7.8293	7.6999
Book value/share	29.1484	32.9232
Debt equity ratio	0.428745	0.483641

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	55,893m	55,624m
Current liabilities	50,321m	54,126m
Total capital	102,141m	120,982m
Total debt	36,634m	47,933m
Total equity	71,490m	81,544m
Total non current liabilities	-	-
Loans	30,651m	39,438m
Total assets	180,104m	199,210m
Total liabilities	-	-
Cash and cash equivalents	24,105m	19,709m
Common stock	2,407m	2,408m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	21,859m	24,105m
Cash dividends paid	-11,823m	-12,381m
	18,059m	19,313m
Investments (gains) losses	-18,599m	-23,588m
	24,105m	19,709m
Net income	-	-
	24,266m	24,530m
	-6,207m	-5,217m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.